Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

PRAX

Praxis Precision Medicines (PRAX)

Praxis Precision Medicines Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PRAX
DateHeureSourceTitreSymboleSociété
23/12/202422h13Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:PRAXPraxis Precision Medicines Inc
20/11/202403h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
14/11/202423h50Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PRAXPraxis Precision Medicines Inc
14/11/202420h32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
08/11/202420h17Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:PRAXPraxis Precision Medicines Inc
06/11/202413h59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRAXPraxis Precision Medicines Inc
06/11/202413h57Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRAXPraxis Precision Medicines Inc
26/09/202414h00GlobeNewswire Inc.Praxis Precision Medicines presents on ulixacaltamide Essential3 program at the Movement Disorders Society 2024 International CongressNASDAQ:PRAXPraxis Precision Medicines Inc
10/06/202422h56Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:PRAXPraxis Precision Medicines Inc
12/04/202414h00GlobeNewswire Inc.Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual MeetingNASDAQ:PRAXPraxis Precision Medicines Inc
05/03/202415h08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PRAXPraxis Precision Medicines Inc
05/03/202413h33Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PRAXPraxis Precision Medicines Inc
05/03/202413h12Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PRAXPraxis Precision Medicines Inc
15/02/202402h45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PRAXPraxis Precision Medicines Inc
12/01/202423h20Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PRAXPraxis Precision Medicines Inc
10/01/202422h19GlobeNewswire Inc.Praxis Precision Medicines, Inc. Announces Proposed Public OfferingNASDAQ:PRAXPraxis Precision Medicines Inc
28/11/202313h00GlobeNewswire Inc.Praxis Precision Medicines to Showcase Largest Pipeline of Precision Epilepsy Programs and Breadth of Commitment to Epilepsy Treatments at Upcoming MeetingsNASDAQ:PRAXPraxis Precision Medicines Inc
21/11/202322h00GlobeNewswire Inc.Praxis Precision Medicines to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:PRAXPraxis Precision Medicines Inc
16/11/202314h00GlobeNewswire Inc.Praxis Precision Medicines Receives PRIME Designation from the EMA for elsunersen (PRAX-222) for Treatment of SCN2A Gain of Function Developmental EpilepsiesNASDAQ:PRAXPraxis Precision Medicines Inc
07/11/202313h00GlobeNewswire Inc.Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2023 Financial ResultsNASDAQ:PRAXPraxis Precision Medicines Inc
02/11/202313h00GlobeNewswire Inc.Praxis Precision Medicines to Present at Truist Securities BioPharma SymposiumNASDAQ:PRAXPraxis Precision Medicines Inc
16/10/202313h09Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PRAXPraxis Precision Medicines Inc
04/10/202313h56Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PRAXPraxis Precision Medicines Inc
02/10/202319h17GlobeNewswire Inc.Praxis Precision Medicines Provides Portfolio Update at 2023 R&D DayNASDAQ:PRAXPraxis Precision Medicines Inc
27/09/202322h15GlobeNewswire Inc.Praxis Precision Medicines To Host Hybrid R&D Day on Monday, October 2, 2023NASDAQ:PRAXPraxis Precision Medicines Inc
19/09/202316h25AllPennyStocks.comBiotech Catches Major Premarket BidNASDAQ:PRAXPraxis Precision Medicines Inc
07/09/202314h00GlobeNewswire Inc.Praxis Precision Medicines to Present at H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:PRAXPraxis Precision Medicines Inc
31/08/202314h00GlobeNewswire Inc.Praxis Precision Medicines to Present Data from Epilepsy Portfolio at the 35th International Epilepsy CongressNASDAQ:PRAXPraxis Precision Medicines Inc
09/08/202313h00GlobeNewswire Inc.Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2023 Financial ResultsNASDAQ:PRAXPraxis Precision Medicines Inc
08/08/202313h00GlobeNewswire Inc.Praxis Precision Medicines Announces Positive Data from Randomized Withdrawal Sub-Study and Long-Term Extension of Essential1 Study for UlixacaltamideNASDAQ:PRAXPraxis Precision Medicines Inc
 Showing the most relevant articles for your search:NASDAQ:PRAX

Dernières Valeurs Consultées